Heart pill shows promise in small Right-Failure trial
NCT ID NCT03344159
First seen May 06, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it safely reduces heart strain and improves nerve function. Participants took the drug or a placebo, and researchers measured changes in heart stress and activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W7, Canada
Conditions
Explore the condition pages connected to this study.